XenoPort, Inc.
(NASDAQ:XNPT)|
29.06 +1.82 (6.68%) Jan 08 - Close |
|
|
|
After-Hours 29.05 -0.01 (-0.03%) Thu, 8 Jan 2009 7:40 PM
- Compare XNPT with:
- View: Line | Candlestick
Company Profile
XenoPort, Inc.
3410 Central Expressway
Santa Clara, CA 95051
United States - Map
Phone: (408) 616-7200
Fax: (408) 616-7210
Website: www.xenoport.com
State of incorporation: Delaware
CEO: Dr. Ronald W. Barrett, Ph.D.
Employees: 181
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
biopharmaceutical company
A biopharmaceutical Company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs.
Recent news for XNPT
-
XenoPort to Present at the 27th Annual J.P. Morgan Healthcare Conference
Business Wire - Jan 06 at 1:30 ET
-
Amazon.com, Res-Care are big movers
AP - Dec 30 2008 at 7:12 ET
-
EDGAR Online - Dec 30 2008 at 5:05 ET
-
Amazon.com, Res-Care are big movers
AP - Dec 30 2008 at 1:01 ET
-
XenoPort to sell $40 million in stock, warrants
AP - Dec 30 2008 at 11:50 ET
-
XenoPort plans $40M stock sale
bizjournals.com - Dec 30 2008 at 10:05 ET
-
XenoPort Announces $40 Million Registered Direct Financing
Business Wire - Dec 30 2008 at 6:30 ET
-
XENOPORT INC Files SEC form 8-K, Other Events
EDGAR Online - Dec 30 2008 at 6:01 ET
-
Coverage initiated on Xenoport by Piper Jaffray
Briefing.com - Dec 16 2008 at 7:25 ET
-
Movers roundup: Bank of New York, XenoPort
AP - Dec 03 2008 at 3:25 ET